Introducing Lixisenatide, a revolutionary medication developed by Henan Yuanlong Biotechnology Co., Ltd. This innovative product is a glucagon-like peptide-1 receptor agonist (GLP-1RA) that is used to improve blood sugar control in adults with type 2 diabetes mellitus. Lixisenatide works by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner.
As a leading manufacturer, supplier, and factory in China, Henan Yuanlong Biotechnology Co., Ltd. is dedicated to providing high-quality pharmaceutical products to improve the health and well-being of individuals around the world. Lixisenatide is just one example of our commitment to developing effective treatments for chronic diseases.
With its proven efficacy and safety profile, Lixisenatide is an important addition to the management of type 2 diabetes. It offers patients and healthcare professionals a valuable option for addressing this widespread health concern. Henan Yuanlong Biotechnology Co., Ltd. is proud to offer this life-changing medication and is committed to advancing the field of diabetes care through ongoing research and development.